Psychiatry and Neurology, Neurology · Milwaukee, WI
NPI
1942213996
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
9200 W Wisconsin Ave, Department of Neurology
Milwaukee, WI, 53226
Phone (414) 805-9719
Groups this clinician bills Medicare through
Medicare paid, 2024
$10K
149 services
Medicare patients, 2024
73
Average age 59
Drug cost, 2024
$768K
1,432 prescriptions
Company payments, 2025
$135
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan W Florczak was code 64615 (musculoskeletal), 36 times for 14 patients. In total Jonathan W Florczak billed 149 services in 15 codes, and Medicare paid $10K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-10-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 64615 Musculoskeletal | Facility | 36 | 14 | $82.92 | $2,985 |
| 99214 Office E&M - Established | Facility | 27 | 25 | $68.80 | $1,858 |
| 99213 Office E&M - Established | Facility | 23 | 20 | $44.66 | $1,027 |
| 99215 Office E&M - Established | Facility | 21 | 17 | $93.90 | $1,972 |
By year: 2022 $12K for 186 services; 2023 $12K for 190 services; 2024 $10K for 149 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan W Florczak prescribed most often to Medicare patients was Emgality Pen (Galcanezumab-Gnlm), with 172 prescriptions and refills. In total Jonathan W Florczak wrote 1,432 Medicare prescriptions that cost $768K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Emgality Pen Galcanezumab-Gnlm | 172 | 218 | 27 | $150K |
| Nurtec Odt Rimegepant Sulfate | 154 | 162 | 24 | $285K |
| Sumatriptan Succinate Generic | 95 | 113 | 17 | $13K |
| Gabapentin Generic | 94 | 158 | 19 | $3,371 |
| Aimovig Autoinjector Erenumab-Aooe | 74 | 142 | 15 | $102K |
| Topiramate Generic | 73 | 181 | 23 | $1,020 |
| Rizatriptan Rizatriptan Benzoate | 66 | 67 | 13 | $1,086 |
| Tizanidine Hcl Generic | 54 | 94 | 15 | $892 |
| Naratriptan Hcl Generic | 52 | 54 | 13 | $1,208 |
| Ubrelvy Ubrogepant | 48 | 48 | 14 | $55K |
| Eletriptan Hbr Eletriptan Hydrobromide | 30 | 30 | Under 11 | $3,279 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 28 | 54 | Under 11 | $37K |
| Qulipta Atogepant | 28 | 28 | Under 11 | $29K |
| Zolmitriptan Generic | 27 | 27 | Under 11 | $16K |
| Doxepin Hcl Generic | 24 | 62 | Under 11 | $1,580 |
Brand drugs: 536 claims; generic drugs: 896 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan W Florczak $135 ($135 in general payments such as food, travel and fees) from 1 company. The largest payer was Axsome Therapeutics, Inc. with $135.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 1 | $135 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.